Zai Lab Executives Conduct Series of Share Sales
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Du Ying | Chairperson & CEO | Sell | $3,345,606 | Form 4 |
| Lis William | Director | Sell | $494,699 | Form 4 |
| Edmondson Frazor Titus Iii | Chief Legal Officer | Sell | $479,661 | Form 4 |
Du Ying, Chairperson & CEO of Zai Lab Ltd, sold 100,000 American Depositary Shares between February 28 and March 3, 2025, at weighted average prices ranging from $31.7479 to $35.055, totaling $3,345,606. Following these transactions, Du Ying directly owns 494,117 shares of the company. The sales were executed under a Rule 10b5-1 trading plan adopted on November 20, 2024.
Lis William, a Director at Zai Lab Ltd, sold 15,000 shares on February 28, 2025, at a price of $32.98 per share, totaling $494,699. Post-sale, William directly owns 38,089 shares. This sale was also conducted under a Rule 10b5-1 trading plan adopted on November 20, 2024.
Edmondson Frazor Titus III, Chief Legal Officer of Zai Lab Ltd, sold 14,544 shares on February 28, 2025, at a price of $32.98 per share, totaling $479,661. Following this transaction, Titus III directly owns 14,328 shares.